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SUMMARY 
The DNA synthetic response to sheep erythrocytes and in a 
graft-versus-host reaction of adoptively transferred cortisone 
resistant thymocytes was measured in irradiated mice and compared 
to the response of thymocytes harvested from untreated donors. 
It is generally believed that cortisone resistant thymocytes 
are the only immunocompetent cells in the thymus. 
Results indicate that 
1. Cortisone sensitive thymocytes are not inert and account 
for a significant portion of thymocyte response in a graft-versus- 
host reaction. 
2. Cortisone resistant thymocytes respond to antigen by a 
markedly different pattern of DNA synthesis than untreated thymo¬ 
cytes, being chiefly a more labile population. This suggests that 
there exist interactions between cortisone-sensitive and cortisone 
resistant thymocyte populations. 
3. Direct evidence is presented that cortisone resistant 
thymocytes may exert immunosuppressive effects on whole thymocyte 
populations. 
4. A role is proposed for variations in the corticosteroid 
secretion rate, related to stress, as a possible nonspecific con- 
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trolling factor in the mediation of thymus-derived lymphocyte 
responses to antigen. 
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I. INTRODUCTION 
1. Corticosteroid-Lymphocyte Interactions 
Interrelations between adrenal cortical steroids and the 
immune system were first noted by Thomas Addison (1) who described 
lymphoid hyperplasia in patients suffering from adrenal insuffi¬ 
ciency. With the isolation of relatively pure adrenal cortical 
preparations in the 1940's, it became apparent that lymphocytes, 
and in particular thymic lymphocytes, were exquisitely sensitive 
to small doses of corticosteroids (2, 3). In the thymus, cortico¬ 
steroid administration is followed by marked edema and by exten¬ 
sive dissolution of medium and small cortical lymphocytes (the 
term lymphocytokarryorrhexis was coined by Dougherty to describe 
the "shedding of cytoplasm" observed.) The cytocidal effect of 
corticosteroids on the thymus was the basis of an early in vitro 
bioassay for adrenal steroid activity (4). 
Early experiments indicated an anatomically selective action 
of corticosteroids on the thymus. Dougherty (2, 5) observed that 
medullary reticulendothelial cells and a small population of large 
medullary lymphocytes were relatively resistant to the action of 
corticosteroids. Ishidate and Metcalf (6) showed evidence of 
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vigorously dividing cortisone resistant lymphocytes clustered around 
PAS-positive reticulum cells. Esteban (7) demonstrated that short¬ 
lived thymocytes were most susceptible to the destructive effects 
of corticosteroids. 
Attempts to elucidate corticosteroid mechanisms of action on 
thymocytes have met with mixed success. On the basis of in vitro 
experiments (8, 9, 10, 11) it appears that a hydroxyl-group on 
the 11-beta position is essential for steroid action on thymocytes. 
Cortisone, thus, must be converted to cortisol (hydrocortisone) by 
reduction at the 11 position, a reduction readily achieved in vivo 
by the liver (12). 
Major biochemical effects of cortisol on thymocytes are inhi¬ 
bition of RNA, DNA, and protein synthesis and decreased transport 
of nucleic acid and protein precursors into the cells (12 - 18). 
Inhibition of DNA synthesis may in part be due to direct inhibition 
of thymidine kinase (20). The relation of these biochemical phe¬ 
nomena to lymphocytolysis is unclear (21). 
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Recent evidence suggests that steroid effects are mediated 
by corticosteroid binding to specific nuclear receptors (22). 
There appear to be about 5000 glucocorticoid binding sites, lo¬ 
cated in the nucleus (not on the nuclear membrane). A protein- 
steroid complex is rapidly formed after incubation of thymocytes 
with cortisol (23). There is little evidence for any action on 
cytoplasmic membranes. 
A probable biochemical mechanism for the apparent selective 
steroid effect on cortical thymocytes may be extrapolated from 
the literature. Dougherty et al. (5) demonstrated that the ability 
to resist cortisol cytolysis depends on the ability of the lympho¬ 
cyte to oxidize cortisol to biologically inactive cortisone, hence 
protecting itself from cytocidal effects. Though no direct proof 
has been published, it would seem plausible to assume that corti¬ 
sone resistant thymocytes resemble peripheral lymph node lympho¬ 
cytes in the presence of 11-beta-hydroxysteroid dehydrogenase on 
their cell membranes and are hence resistant to the action of 
cortisol. 
It is interesting to speculate on the biological implications 
of steroid-lymphocyte interactions. Ambrose (24, 25) has docu¬ 
mented an absolute requirement for cortisol in in vitro antibody- 
synthesizing organ culture systems. Under these conditions. 
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physiological levels of cortisol are essential, yet higher concen¬ 
trations inhibit antibody synthesis. On the basis of elegant 
biochemical studies, the author concluded that the "permissive" 
effect of corticosteroid in the formation of antibody involved 
the derepression of genes by unmasking sites of the DNA of chromatin 
for attachment of natural signals or inducers. Whether this is a B 
or T cell effect is unknown. 
It seems likely, however, that T-cells would be affected, in 
view of their known greater sensitivity to steroid effects (26, 
27). The effects of stress, and its concomitant increased cortico¬ 
steroid secretion rate, on the immune response may in part be due 
to genetic derepression events on regulatory T-cells (28). 
Whatever the teleological reasons for steroid-lymphocyte 
interactions, it seems unlikely that the adaptations of lympho¬ 
cytes to corticosteroids are purely accidental. 
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2• Functions of Thymic and Thymus-Derived Lymphocytes 
In the past decade, it has become clear that the thymus is 
fundamental to the immune response, both cellular and humoral. 
Lymphocytes derived from the bone marrow enter the thymus; an 
unknown proportion of these leave the thymus after an undetermined 
time and are fundamentally changed as a result of their sojourn. 
The present state of knowledge of thymus physiology has been 
reviewed extensively elsewhere (29) and will be outlined only 
briefly here. 
Essentially, the thymus may be regarded as a producer of long- 
lived "thymus-derived lymphocytes", or "T-cells." Far more is 
known about the behavior of these cells than is known about the 
processes involved in their production and differentiation, a 
topic to be considered later. Thymus-derived lymphocytes are 
relatively small (8 microns), have a large nuclear:cytoplasmic 
ratio, and have been shown to be long-lived (30). In humans, 
their life span ranges in excess of 15 - 20 years, and they have 
been estimated to constitute 80% of peripheral blood lymphocytes 
(31). Thymus-derived lymphocytes have the property of recirculating, 
that is, they pass intracellularly from the blood through the pos- 
capillary venules of lymph nodes, enter the lymph nodes and travel 
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through the lymphatic system, ultimately re-entering the blood 
through the major lymphatic ducts. Recirculation through the 
spleen has also been demonstrated. 
"T-cells" are to be distinguished from short-lived "B-cells", 
or bone-marrow derived lymphocytes, which have not passed through 
the thymus and do not recirculate. 
Thymus-derived lymphocytes carry on their surfaces a dis¬ 
tinctive antigen, termed theta (0), and tend to localize in 
specific "thymus dependent" areas of the lymphoid system, namely 
the paracortex of lymph nodes and the periarteriolar sheathes of 
the spleen (33). They are the prime participating cells in 
delayed hypersensitivity reactions (cellular immunity), and appear 
to be the source of the chemical mediators of these reactions. 
It is also well documented that thymus-derived lymphocytes 
are capable of mounting graft-versus-host reactions (34, 35). 
They are also capable of blast transformation in response to 
phytohemagglutinin and other mitogens (36) , and participate in 
mixed lymphocyte reactions (58). Chromosome labelling studies 
have shown them to undergo mitosis in response to antigen (37). 
This response can be reduced by pretreatment with the same antigen 
(38). 
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3• Thymus-Derived Lymphocytes as Interacting Cells 
Thymus-derived lymphocytes are incapable of producing anti¬ 
bodies when infused into lethally irradiated hosts (39, 40). A 
major advance of the past few years, however, was the demonstration 
by Claman and Chaperon in 1967 that thymus-derived lymphocytes 
are capable of interacting synergistically with bone-marrow-derived 
lymphocytes in the formation of antibody (30). The validity of 
this finding is no longer in doubt, but is interpretation remains 
a matter of conjecture. The mechanisms proposed for lymphocyte 
cooperation have been reviewed by Miller et al. (40) and have 
chiefly attributed antigen concentration as a property of T-cells, 
antibody production as a property of B.-cells. T-cells, which 
contain on their surfaces small amounts of immunoglobulin, are 
thought either to focus antigen passively onto B-cells by 
antigen-bridging; or perhaps to interact specifically with antigen, 
differentiating, dividing, and producing a factor or factors 
mediating the induction of the immune response. The putative 
factor has been termed by some IgX, though there is no direct 
evidence for its being an immunoglobulin. 
Whatever the nature of T-cell interactions, an impressive 
body of literature has arisen incriminating such interations in 

-10- 
various immunological phenomena. In addition to their by now well- 
documented role in cooperation with B-cells to form at least some, 
if not all antibodies, T-cells have been demonstrated to cooperate 
with bone marrow in the production of graft-versus-host spleno¬ 
megaly (41). Cantor and Asofsky (42) have reported synergistic 
interactions between thymic lymphocytes and splenic and lymph node 
lymphocytes in the production of graft-versus-host reactions; 
these results may be interpreted as evidence for the existence of 
T-cell interactions with other T-cells. 
Recent evidence supports the concept of negative interactions 
among thymus-derived and other lymphocytes. Gershon and Kondo (42) 
demonstrated a key role for thymus-derived lymphocytes in the 
induction and breaking of tolerance to sheep erythrocytes in mice, 
and more recently have shown that T-cells from mice made unrespon¬ 
sive to sheep erythrocytes are capable of blocking the antibody 
response to this antigen even in fully reconstituted bone marrow 
chimera mice (44). Antigenic competition, the mechanism whereby 
administration of antigen leads to diminished response to subse¬ 
quent administration of unrelated antigen, has been shown to be 
a T-cell mediated phenomenon (45). Baker (46) presented further 
evidence for an immunosuppressive role for T-cells in experiments 
where thymus deprived mice were shown to produce excess antibody 
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to certain antigens; In these animals the addition of T-cells was 
shown to depress the excess antibody titres. 
Herzenberg (47) presented an intriguing model of suppressive 
interactions between lymphoid cells to explain "allotypic suppression" 
in inbred mice. In this phenomenon, FI mice, immunoglobulin allo¬ 
type a/b, are exposed in vitro or neonatally to anti-b antibody. 
They are subsequently unable to express the b immunoglobulin allo¬ 
type. This suppression seems to be due to supressive T-cells, lasts 
for years, and can be transmitted by adoptive transfer of allotypic 
lymphoid cells. 
Gershon et al. (48) presented three different instances in 
which T-cells, in the absence of B-cells or antibody, could suppress 
the DNA synthetic response of other T-cells. "Educated" T-cells, 
harvested from spleens of antigen-challenged mice and adoptively 
transferred to irradiated recipients, were demonstrated to reduce 
the DNA synthetic response of "naive", unchallenged T-cells to 
sheep erythrocytes; FI T-cells were observed to decrease the mitotic 
graft-versus-host response of parental T-cells administered to 
irradiated FI mice; and cortisone-resistant T-cells were shown to 
cause a much reduced DNA synthetic response to sheep erythrocytes 
when combined with thymocytes harvested from untreated donors and 
adoptively transferred into lethally irradiated hosts. 

-12- 
Allison (49, 50) has attempted to unite under one formulation 
evidence for both negative and positive T-cell interactions. What¬ 
ever the mechanism turns out to be, it seems clear that T-cells 
play a fundamental regulatory role in immunity and are capable of 
initiating and promoting the immune response as well as being able 
to slow down or stop it. Liebhaber and Gershon (manuscript in 
preparation) have accumulated evidence for a bidirectional regula¬ 
tory role of T-cells. In experiments on the kinetics of T-cells 
in graft-versus-host reactions, it was observed that, depending 
on the relative numbers of cells involved, FI T-cells could exert 
either stimulatory or inhibitory effects on a graft-versus-host 
reaction initiated by infusing parental thymocytes into irradiated 
FI mice. 
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4. Heterogeneity of Lymphocytes within the Thymus 
In the current view, the thymus is thought of as a compartment 
in which lymphocytes become unalterably changed before release 
into the circulation as small, recirculating, lymph-node seeking 
"T-cells", paramount in cell mediated immunity and of great im¬ 
portance in many, if not all humoral immune reactions. Under¬ 
standably, much interest has centered around the nature of the 
intrathymic lymphocyte "education" process. 
It is known that thymic lymphocytes are extraordinarily 
active mitotically (51). The fate of the large volume of lympho¬ 
cyte traffic in the thymus is not completely understood, but it 
is probable that lymphocytes enter the thymic cortex from the 
bone marrow, progressively decrease in size, migrate to the 
medulla of the thymus, and thence leave via the thymic vein to 
enter the paracortexes of peripheral lymph nodes and the peri- 
arteriolar sheathes of the spleen (52 - 55). 
Though intrathymic lymphocytes are immunologically weak in 
comparison with lymph node and spleen lymphocyte populations 
(known to be rich in T-cells), nevertheless thymic lymphocytes 
possess definite immunologic competence in graft-versus-host 
reactions, in cooperation with B-cells to form antibody, and as 
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measured by mitotic response to allogenic cells and to mitogens 
(56). 
With the realization that thymic lymphocytes possessed a 
degree of immunologic competence, evidence began to appear that 
such competence was not uniformly distributed among thymocytes. 
Warner (57), in 1964, showed that medullary cells of the 
chick thymus, selected by their resistance to cortisone, were a 
far more immunologically competent population than thymic cortical 
cells, as judged by their ability to injure chick chorioallantoic 
membrane. Weber (58), in 1966, showed that phytohemagglutinin 
responding cells in the pig thymus were cortisone resistant and 
localized in the thymus medulla, and in 1970 demonstrated that 
these medullary thymocytes were able to participate in mixed 
lymphocyte reactions almost as well as splenic lymphocytes; in 
contrast, cortical thymocytes were said to show negligible partici¬ 
pation (59) . 
Blomgren and Andersson (56), in 1969, showed that cortisone 
resistant thymocytes were far more active, per cell, in inducing 
graft-versus-host splenomegaly than were suspensions of thymocytes 
derived from untreated mice. The interpretation that the cortisone 
resistant thymocytes represented a population similar to peripheral 
lymph node lymphocytes was supported by the observation that the 
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volume distribution of these two groups of cells was identical. 
Cohen, Fischbach, and Claman (26) confirmed that cortisone 
resistant thymocytes were highly active in a graft-versus-host 
system and also found that cortisone resistant spleen and marrow 
lymphocytes were more active than comparable untreated cells in 
initiating graft-versus-host splenomegaly. 
Andersson and Blomgren (60) showed in 1970 that the cortisone 
resistant fraction accounted almost entirely for the capacity of 
thymocytes to cooperate with bone marrow in the restoration of 
the humoral antibody response to sheep erythrocytes, bovine serum 
albumin, ovalbumin, and NIP determinant in lethally irradiated, 
thymectomized mice. Similarly, Cohen and Claman (61) observed 
that cortisone resistant thymocytes were highly active in inter¬ 
acting with bone marrow to form anti-sheep erythrocyte Jerne 
plaques in the spleens of bone marrow chimera mice. Further, the 
proliferation of thymus cells, once infused into recipients, was 
found to be uninfluenced by hydrocortisone (62). 
Blomgren (63), in 1971, studied volume changes occurring 
when allogeneic thymocytes were infused into lethally irradiated 
mice and concluded that cortisone resistant medullary thymocytes 
were the sole thymocyte sub-population undergoing blastoid trans¬ 
formation in response to H-2 antigens. Blomgren and Andersson 
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(64), in 1971, confirmed the idea that medullary cortisone resistant 
thymocytes were highly effective in producing graft-versus-host 
reactions and in restoration of antibody production in bone marrow 
chimeras; they further concluded from these studies that cortical, 
cortisone sensitive thymocytes were inert in both of these immuno¬ 
logical phenomena. 
Cortisone resistant mouse thymocytes were found by Blomgren 
and Svedmer, in 1971, to be highly responsive in vitro to 
phytohemagglutinin and highly reactive in a mixed lymphocyte 
reaction, confirming Weber’s earlier similar experiments with pig 
tissues; furthermore, cortisone resistant thymocytes were said to 
be transformed into specific "killer cells", toxic to allogeneic 
fibroblasts, when cultured with allogeneic mitomycin-treated cells 
with the same major histocompatibility antigens (65). 
Schimpl and Wecker, in 1971, deprived mouse spleen cell 
suspensions of their T-cells by treatment with anti-6 serum and 
complement; such suspensions were unable to respond significantly 
to sheep erythrocytes. Whereas ordinary thymocytes failed to 
restore the hemolysin response, thymocytes from hydrocortisone- 
treated mice were able to reconstitute the system fully (66). 
Bach and Dardenne, in 1971, found that cortisone treatment 
of mouse thymuses augmented the percentage of spontaneous rosette 

-17- 
forming cells but that the actual number per thymus of rosette 
forming cells was unchanged (67). 
In chromosome labelled thymus graft studies, Elliot et al., 
in 1971, presented direct evidence that the small phytohemagglutinin- 
responsive cell population in the thymus, while probably cortisone 
sensitive itself, is derived from the cortical cortisone sensitive 
population (68). 
The theta (6) surface antigen, mentioned above, has been 
shown to be a marked of thymus-derived lymphocytes in mice (69). 
Thymic lymphocytes have high 0-titres; and bone marrow-derived 
lymphocytes have zero titre. Cortisone resistant thymocytes were 
found by Raff in 1971 to have 0 titres similar to those of peri¬ 
pheral T-cells and in Cr^ labelling studies were observed to 
have the same migratory pattern as peripheral thymus-derived 
lymphocytes (70). 
The TL (thymus leukemia) antigen, like 0, has served as a 
useful marker in identifying thymic lymphocytes. In TL+ strains 
of mice, most thymocytes have high TL titres but the antigen is 
absent from extra-thymic lymphocytes (70) . Schlesinger and 
Golakai, in 1967, presented good evidence that the small proportion 
of TL- thymocytes represented the same population as cortisone 
resistant thymocytes (71). Leckband and Boyse, in 1971, demon- 
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strated that the graft-versus-host potential of thymocytes is almost 
totally confined to TL- cells (72). Raff, in 1971, found that 
TL- thymocytes, like low-titre 0+ thymocytes, migrated to spleen 
and lymph nodes in a pattern indistinguishable from peripheral 
thymus-derived lymphocytes (70). 
Colley, Shih-Wu, and Waksman have recently fractionated thymo¬ 
cyte populations by differential flotation in bovine serum albumin 
(73, 74). It appeared from these experiments that most of the 
immunocompetent thymic cells were located in three of five discrete 
bands, termed A, B, and C. However, these putatively immunocompetent 
thymocytes lacked certain characteristics of peripheral lymphoid 
cells, and possessed a different distribution. 
A large body of evidence exists, then, suggesting that a 
small population of medullary thymocytes, which are cortisone 
resistant, TL-, low grade 0+, recirculating, and constitute per¬ 
haps 3-5% of the total cells in the thymus (56) — are a highly 
active immunocompetent cell population within the thymus. These 
findings, however, have been interpreted as meaning that cortisone 
resistant thymocytes are the only immunocompetent cells in the 
thymus (56, 60, 61, 63 - 65). In this thesis, data is presented to 
the contrary, and its is proposed that there may be several inter¬ 
acting cell populations of immunological importance within the thymus. 
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II. EXPERIMENTAL 
1. Experimental Plan 
In a system free of B-cells and antibody, the DNA synthetic 
response of cortisone resistant and other T-cells to sheep erythro¬ 
cytes and in a graft-versus-host reaction was studied. Attempts 
were made to demonstrate cellular interactions between cortisone 
resistant thymocytes and other thymocytes. 
2 . Materials and Methods 
Mice: Male C3H and C3D2F1 (C3H X DBA2) were obtained from 
Jackson Laboratory, Bar Harbor, Maine. Mice were rested 
in the animal facility for one week before use. Thymocyte 
donors were 5 weeks old, recipients were 8 weeks old. 
Irradiation: A Siemens Stabilipan 250 KV X-Ray machine, 
with 2 mm. A1 filter, was used for irradiation of recipients. 
They were placed in a plexiglass chamber on a rotating plat¬ 
form and received 900 R at a dose rate of 85 R per minute. 
In experiments involving in vitro irradiated cell suspen¬ 
sions, these were contained in non-leaded glass tubes, kept 
ice-cold, and were slowly rotated while receiving a total of 
900 R of X-irradiation at a rate of 85 R per minute, using 
the Siemens 250 KV machine with 2 mm. A1 filter. 
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Sheep Erythrocytes: These were maintained in refrigerated 
Alsever’s solution and washed three times before use. They 
were inoculated intraperitoneally into recipient mice in a 
volume of 0.2 ml. 
Cell Suspensions: Donor mice were killed by cervical dis¬ 
location and thymuses carefully dissected out under sterile 
conditions. Thymuses were then gently squeezed between two 
sterile glass slides. Cell suspensions thus obtained were 
then filtered through three layers of gauze and washed twice 
in ice-cold sterile medium 199 containing 100 units/ml. of 
penicillin, streptomycin and kanamycin and 10 units/ml. 
heparin. Viable cell counts were made with a hemocytometer 
using the trypan blue dye exclusion method (4). 
Cortisone: Donor mice were given IP injections of 2.5 mg. 
cortisone acetate ("Cortone”, Merck, Sharpe, and Dome). 
These and untreated animals were sacrificed 48 hours later 
and cell suspensions were then made from their thymuses. 
Cell Inoculations: These were given intravenously via tail 
vein. The inoculated volume never exceeded 0.2 ml. 
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Technlque for Assaying DNA Synthesis of Thymocytes: This 
technique is described in detail by Gershon and Hencin (75). 
Lethally irradiated mice were inoculated with the appropriate 
experimental suspension of thymocytes on Day 0 of the experi¬ 
ment. On the day of assay of DNA synthesis, mice were given 
1 X 10 ^ moles of 5-fluoro-2-deoxyuridine I.P. This com¬ 
pound inhibits the formation of endogenous thymidine from 
deoxyuridine monophosphate (76). One hour later these mice 
received an I.P. injection of two microcuries of 5-iodo-2- 
125 125 
deoxyuridine labelled with I ( IUDR). (Amersham/ 
Searle, specific activity 4-6 microcuries per microgram). 
125 
The IUDR is incorporated into DNA in the place of thymidine 
monophosphate (76, 77). Twenty-four hours later the animals 
were killed and the spleens and in some cases femoral lymph 
nodes were dissected out and placed in counting tubes con¬ 
taining formalin. At the termination of the experiment, the 
spleens and nodes were counted for six minutes in a Nuclear- 
Chicago scintillation counter. Also counted at this time 
125 
was a standard aliquot of 0.2 ml. IUDR from the same lot 
used in inoculating the test animals. The counts in the 
experimental tubes were divided by the counts of the standard, 
and the result was expressed as percent uptake of isotope. 
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All counts were corrected for background. Results were 
expressed as uptake on a given day (e.g., Day 2). This 
125 
refers to the day of pulse injection of the IUDR, i.e., 
in this case two days after inoculation with thymocytes. 
One day later the animal was killed and its spleen removed. 
Interpretation of Data 
Where appropriate, results were compared using Student's 
t-test. 
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III. RESULTS 
These experiments were performed with several objectives in 
mind. The first was to observe the behavior of cortisone resistant 
thymocytes, compared to that of unfractionated thymocyte popula¬ 
tions, in a relatively new assay system free of B-cells and anti¬ 
body. The aim was to test the widely held notion that cortisone 
resistant thymocytes represent the sole immunocompetent intra- 
thymic cell population. This was investigated both in response 
to sheep erythrocytes and in a graft-versus-host reaction. In 
addition, repeated attempts were made to document interactions 
between cortisone resistant thymocytes and whole thymocyte sus¬ 
pensions, and also between these cells after in vitro lethal 
irradiation. 
1. DNA Synthetic Response to Sheep Erythrocytes 
A. Response to a Single Challenge with Sheep Erythrocytes: 
In several experiments, lethally irradiated C3D2F1 mice 
received intravenous infusions of syngeneic thymocytes and were 
challenged with one dose of sheep erythrocytes (0.2 ml. of a 10% 
suspension injected intraperitoneally) immediately thereafter. 
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The animals received an intraperitoneal injection of 10 moles 
of 5-fluoro-2-deoxyuridine on the day of assay, followed one hour 
125 
later by an IP pulse of two microcuries of IUDR. Twenty-four 
hours later, these mice were sacrificed by cervical dislocation 
and their spleens dissected out. The spleens were counted in a 
scintillation counter at the conclusion of the experiment and the 
percent uptake of infused radioisotope was calculated as described 
in the "Methods" section. Percent uptake is expressed as uptake 
125 
on the day of pulse infusion of IUDR. 
A consistent finding in several experiments was the much 
higher isotope uptake, per cell, of cortisone resistant thymocytes 
compared to cells derived from untreated donors. Based on uptake 
per cell of radioisotope, cortisone resistant thymocytes were 
calculated to account for 80 - 90% of the total DNA synthetic 
response of whole thymocyte suspensions to sheep erythrocytes as 
measured in this assay system. In other words, the cortisone 
resistant thymocytes could almost on their own account for the 
entire response of unselected thymocytes to sheep erythrocytes 
(Figure 1 and Table 1). 
The kinetics of isotope uptake of cortisone resistant thymo¬ 
cytes, i.e., the effect of varying the numbers of cells infused, 
was not unlike that observed for whole thymocyte suspensions (75). 
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FIGURE 1: Ratios of isotope uptake, per cell, of cortisone re 
sistant thymocytes: normal thymocytes, in response to multipl 
challenges with sheep erythrocytes (see text). 
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Specifically, a tenfold increase in the number of cortisone 
resistant thymocytes was seen in another experiment to increase 
the isotope uptake by a factor less than ten (Table 2). This 
finding is not in apparent agreement with the in vitro experiments 
of Andersson and Svedmer (65), who reported that cortisone resistant 
thymocytes exhibited greater than first order kinetics, i.e., a 
tenfold increase in cell number resulted in a greater than tenfold 
increase in fibroblast killing activity. 
B. Response to Multiple Challenges with Sheep Erythrocytes 
The responses of cortisone resistant and normal thymocytes 
to multiple I.P. challenges with 0.2 ml. of a 10% sheep erythro¬ 
cyte suspension were compared, using the same experimental system 
described in the previous section. In this experiment, untreated 
donor thymuses yielded 54 times as many cells as cortisone treated 
thymuses. If the cortisone resistant thymocyte population were 
the sole immunocompetent intrathymic population, one would expect 
that these cells would cause about 54 times as much splenic isotope 
uptake per inoculated cell. Indeed, when one dose of antigen was 
administered, the cortisone resistant cell response came close 
to this expectation (Figure 1). With multiple challenges of anti¬ 
gen, however, the relative potency of the cortisone resistant cells 
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TABLE 2 
Number of Cortisone Resistant 
Cells Infused 
2 X 105 
2 X 106 
Total 125IUDR Uptake, 
Minus Control, ± SD 
0.015% ± 0.008 
0.075% ± 0.005 
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appeared to be almost twice as much as would be predicted on 
the basis of their relative numbers. 
In contrast to the response of normal thymocytes, then, the 
response to antigen of cortisone resistant thymocytes was highly 
"boostable" — these cells were able to increase their response 
greatly when challenged with repeated doses of antigen. Con¬ 
sequently, the ratio of their response to the relatively un¬ 
changed response of untreated cells was a function of antigen 
dose (Table 1 and Figure 1). 
C. Evidence for Cellular Interactions 
In a number of experiments, groups of animals received mix¬ 
tures of cortisone resistant and normal thymocytes in attempts 
to document interactions between different thymocyte populations. 
In one experiment (Figure 2) a dramatic negative interaction was 
observed. The addition of 2X10^ cortisone resistant thymocytes 
to 2X10^ normal cells resulted in a combined response to packed 
SRBC much less than the response of 2X10^ normal cells alone. 
(p<.05). This phenomenon occurred on the day of peak response. 
Repeated attempts to confirm this result were suggestive 
but inconclusive. No evidence was found for synergistic inter¬ 
actions between cortisone resistant and normal thymocytes. Figure 
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FIGURE 2: DNA synthesis produced by immunization with 0.2 ml. of 
packed sheep erythrocytes of syngeneic thymocyte populations (see 
(text). 
I - is the peak response of each group, independent 
of which day it occurred. 
II - is the total response, measured daily, subdivided 
into the daily response. 
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3 shows the results of a representative experiment in which addi¬ 
tion of variable numbers of cortisone resistant thymocytes to a 
constant inoculum of untreated thymocytes resulted in a stepwise 
increase in isotope uptake response to SRBC, fully explainable 
by addition of cell responses and not suggestive of synergy. 
Experience in our laboratory with a graft-versus-host system 
(Liebhaber and Gershon, to be published) suggested a possible 
suppressive role for irradiated thymocytes in our assay system. 
Consequently, a pilot experiment was designed to determine 
whether in vitro lethally irradiated (900 R) thymocytes were 
capable of suppressing the response of whole and cortisone treated 
thymocytes to sheep erythrocytes. The results (Figure 4) sug¬ 
gested that lethally irradiated whole thymocyte suspensions might 
depress the response of both cortisone resistant and untreated 
thymocytes on the second day after challenge (p<.025) but this 
was the only day tested and these interactions remain to be fully 
explored. 
2. Behavior of Cortisone Resistant Thymocytes in Graft-Versus- 
Host Reactions 
A series of experiments was undertaken to explore the be¬ 
havior of cortisone resistant cells in graft-versus-host reactions 
involving infusions of C3H allogeneic thymocytes into C3D2F1 re- 

-36- 
FIGURE 3: Splenic uptake of IUDR by various combinations of 
normal and cortisone treated thymocytes. Antigen was 0.2 ml. 
packed SRBC. 
Q . -g 1 X 107 normal thymocytes 
f--4- 1 X 107 normal thymocytes + 2 X 10^ cortisone 
resistant thymocytes 
7 6 0---o 1 X 10 normal thymocytes + 2 X 10 cortisone 
resistant thymocytes 
*.X 2 X 10^ cortisone resistant thymocytes 
L-& 2 X 10^ cortisone resistant thymocytes 
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125 
FIGURE 4: Percent splenic uptake of IUDR in lethally irradiated 
mice given combinations of normal + irradiated thymocytes and 
cortisone resistant + irradiated thymocytes. 
A: 5 X 107 normal thymocytes 
7 7 
B: 5 X 10 normal thymocytes + 5 X 10 lethally irradiated 
thymocytes 
C: IX 10^ cortisone resistant thymocytes 
6 7 
D: 1 X 10 cortisone resistant thymocytes + 5 X 10 
lethally irradiated thymocytes 

A B C D 
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cipients. These two inbred strains of mice differ at the H-2 
locus and it is known that a vigorous graft-versus-host response 
occurs when the parental (C3H) thymocytes are infused into the 
FI (41). 
In a representative experiment, seventeen times as many 
thymocytes were recovered from untreated donor mice compared to 
cortisone treated mice. The cumulative ratios of per cell splenic 
125 
and lymph node IUDR uptake, however, were only about half the 
ratios anticipated if these cortisone resistant cells accounted 
for all the immunocompetent cells participating in the graft-versus- 
host reaction. The relatively poor performance of cortisone 
resistant cells in graft-versus-host reactions has been a constant 
finding in several experiments (Figure 5 and Table 3). 
A. Spleen and Lymph Node Isotope Uptake in Graft-Versus-Host 
Pve act ions 
In most graft-versus-host experiments, both spleens and 
femoral lymph nodes were harvested and counted. Lymph node 
results seemed to parallel spleen results. There was some indi¬ 
cation that cortisone resistant thymocytes preferentially responded 
in lymph nodes (Table 5). 
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FIGURE 5: Ratios of isotope uptake, per cell, of cortisone 
sistant thymocytes:normal thymocytes, in a graft-versus-host 
reaction (see text). 
re- 
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TABLE 5 - Ratios of splenic isotope uptake: lymph node isotope uptake 
in the graft-versus-host reactions described in Tables 8 and 9 
Thymocyte Inoculum Day of Experiment Spleen:Node Uptake Ratio 
4.5 X 107 normal 2 12.9 
" 3 18.0 
" 4 11.4 
Total (2, 3, 4) 14.9 
3.15 X 106 
cortisone resistant 
n 
2 
3 
4 
9.7 
11.7 
7.5 
Total (2, 3, 4) 9.7 
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B• Cellular Interactions in Graft-Versus-Host Reactions 
Several experiments were performed to explore possibilities 
of cell interactions in graft-versus-host reactions. Previous 
experiments (48) had indicated that FI cells might have suppres¬ 
sive effects on graft-versus-host reactions in FI animals. Sup¬ 
pression was often enhanced by administering 900 R of X-irradia- 
tion in vitro to the FI thymocytes before combining them with 
parental cells. 
Consequently, experiments were designed to elicit inter¬ 
actions between cortisone resistant, irradiated, and untreated 
thymocytes in graft-versus-host reactions. 
Marked suppressive interactions ("antergy"') was observed 
6 7 
when 6X10 cortisone resistant FI thymocytes were added to 4X10 
parental thymocytes and the combination infused into FI mice in 
the same experimental system described above. The combined response 
was significantly (p<.05) less than the response of the parental 
cells alone, both in spleen and lymph nodes. When the cortisone 
resistant cells were exposed to 900 R of X-irradiation before 
combination with the parental cells, an even greater suppression 
(p<.005) occurred (Figure 6). As noted in sheep erythrocyte ex¬ 
periments, optimum suppressive effect occurred late in the response, 
in this case, one day after peak response. 
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FIGURES 6 and 7: Effect of combining in vitro irradiated thymo¬ 
cytes with normal thymocytes on a graft-versus-host reaction (see 
text). 
ft- --ft 4 X 10 normal C3H thymocytes 
7 6 
O—-O 4 X 10 normal C3H thymocytes + 6 X 10 cortisone 
resistant C3D2F1 thymocytes 
X.X 4 X 107 normal C3H thymocytes + 5 X 10^ in vitro 
irradiated cortisoen resistant thymocytes 
■$.-\ 4 X 107 normal C3H thymocytes + 6 X 10^ in vitro 
irradiated cortisone resistant thymocytes 

%
 
U
PT
A
K
E 
O
F 
12
5I
U
D
R
 
SPLEENS 
/ 
/ 
.05 
2 3 
DAY OF EXPERIMENT 
4 

%
 
U
PT
A
K
E 
O
F 
12
5I
U
D
R
 
.025 
.020 
.015 
.010 
.005 
/ 
• • 
/ 
O 
2 3 
DAY OF EXPERIMENT 
4 

-51- 
In one experiment (not shown) the addition of irradiated FI 
thymocytes to cortisone resistant thymocytes, in the above graft- 
versus-host system, had no apparent effect on uptake. 
C. Response to SRBC in the Presence of a Graft-Versus-Host 
Reaction 
In this experiment, allogeneic (C3H) thymocytes from normal 
and from cortisone treated donor mice were infused into lethally 
irradiated C3D2F1 recipients and DNA synthesis was assayed as 
described above. Some of these recipients, in addition, were 
also given varying numbers of doses of sheep erythrocytes. 
As noted previously, cortisone resistant thymocytes in a 
graft-versus-host reaction were better responders than whole 
thymocytes, but not so strikingly as they were in response to 
SRBC alone (see preceding). When SRBC was added to the graft- 
versus-host reaction, however, the response of the cortisone re¬ 
sistant thymocytes was seen to be markedly enhanced (Figure 8), 
while the untreated thymocytes showed little change in splenic 
uptake of radioisotope. 
Lymph node results indicated that, while the cortisone re¬ 
sistant cell uptake in lymph nodes was greatly increased by two 
doses of antigen, the administration of a third dose decreased up¬ 
take to baselike levels (Figure 8). Uptake of isotope by untreated 
thymocytes did not appear to change with addition of antigen. 
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FIGURE 8: Ratios of uptake, per cell, of cortisoen resistant: 
normal thymocytes, in response to varying doses of SRBC in the 
presence of a graft-versus-host reaction (C3H vs. CDF1). 
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IV. DISCUSSION 
1. Relative Responsiveness of Untreated versus Cortisone Resistant 
Thymocytes 
Whereas previous investigators (56, 60, 61, 63 - 65) have 
favored the view that cortisone resistant cells represent the only 
immunocompetent intrathymic population, evidence is presented 
herein that their relative contribution to total thymus immuno- 
competence varies according to experimental conditions. 
In particular, while cortisone resistant thymocytes account 
for most of the thymocyte DNA synthetic response to sheep erythro¬ 
cytes (Figure 1), they make up only about half the total thymic 
response in a graft-versus-host reaction (Figure 5). These ob¬ 
servations are in accord with the experiments of Blomgren and 
Andersson (56) who reported that cortisone resistant thymocytes 
were only half as reactive in inducing graft-versus-host spleno¬ 
megaly as would be expected were they the sole reacting cells in 
the thymus. Similarly, the results are also in agreement with 
the work of Andersson and Blomgren (60) who showed data indicating 
that cortisone resistant thymocytes were 96% as active in restoring 
sheep hemolysin response in thymectomized, lethally irradiated, 
bone marrow reconstituted mice as would be expected if they alone 
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among thymus cells were capable of responding to antigen. 
Cortisone resistant thymocytes, then, do not perform as 
well in graft-versus-host reactions as would be predicted, but 
they do respond almost as well as would be predicted in response 
to SRBC. The explanation of these observations may be that corti¬ 
sone sensitive thymocytes make significant contributions to the 
DNA synthetic response in the graft-versus-host system. The major 
histocompatibility antigens are far more antigenic than heterologous 
erythrocytes, hence it would be reasonable to expect any immuno- 
competence that these cells might possess to show up best in response 
to the H-2 antigens. The failure of cortisone resistant cells to 
account for 100% of the DNA synthesis in response to SRBC may also 
indicate that cortisone sensitive cells contribute in a small way 
to this reaction. 
2. Different Patterns of Response to Antigenic Stimuli in Untreated 
and Cortisone Resistant Thymocytes 
In this report, numerous instances are shown in which cortisone 
resistant thymocytes behave differently than thymocytes derived 
from untreated donors. In particular, they appear to be a far 
more labile population. 
For instance, cortisone resistant thymocytes show greatly 
augmented responses to repeated challenge with sheep erythrocytes 
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(Figure 1) while the response of untreated thymocytes under the 
same conditions is relatively unchanged. 
Similarly, in a graft-versus-host reaction, cortisone re¬ 
sistant thymocytes are seen to respond markedly to the presence 
of added SRBC, while untreated thymocytes do not (Figure 8). 
When three doses of SRBC are given instead of two, the cortisone 
resistant thymocyte peak response in lymph nodes is diminished. 
The labile response of cortisone resistant thymocytes, con¬ 
trasted with the response of untreated thymocytes, may be inter¬ 
preted as indirect evidence for interactions between the cortisone 
sensitive thymocyte subpopulation and the cortisone resistant 
subpopulation. The presence of cortisone sensitive thymocytes, in 
all instances studied, appears to exert a stabilizing, perhaps 
regulatory effect on the highly responsive cortisone resistant 
cells. If antigenic stimuli are powerful enough the cortisone 
sensitive thymocytes may be capable themselves of responding. 
This phenomenon may be related to the proposed T1 to T2 transition 
model proposed by Raff and Cantor (80). 
3. Localization of Cortisone Resistant Thymocytes 
These experiments showed some evidence (Table 5) that corti¬ 
sone resistant thymocytes preferentially localized in lymph nodes. 
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as judged by the uptake of isotope in lymph nodes during the 
course of a graft-versus-host experiment. This observation is 
51 
in accord with the Cr localizing studies of Lance and Taub 
(78) and Lance and Cooper (79), where it was found that cortisone 
resistant cells indeed did show a tendency to seek out and re¬ 
main in lymph nodes. 
4. Interaction between thymocyte populations: Direct Evidence 
In several experiments evidence is presented to suggest 
interactions between thymocytes. 
First evidence will be considered for positive, "synergistic" 
interactions. This form of cooperation is difficult to prove in 
125 
the IUDR uptake system: whether or not it is valid to expect 
the responses of individual cell populations to add arithmetically 
when these cells are mixed together and infused is not yet deter¬ 
mined. Indeed, initial experience with this system, reported in 
part by Gershon and Hencin (75) , suggested that the splenic iso¬ 
tope uptake is not a linear function of cell dose, i.e., that 
doubling the number of infused cells results in considerably less 
than twice the splenic isotope uptake. Furthermore, at least in 
SRBC experiments, "background" response — that is, uptake in the 
absence of antigen — accounts for a significant but variable 
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proportion of total uptake, depending mostly upon the absolute 
value of the latter. Background undoubtedly also is in part due 
to as yet unknown or uncontrollable variable, such as DNA synthesis 
in response to infection in the lethally irradiated animal. 
Keeping in mind, then, the inherent unresolved mathematical 
problems in interpreting these data, attention is directed toward 
the apparent additive effects on total DNA synthesis that result 
from combining thymocyte populations (Figure 3). These are not 
suggestive of cooperation, but rather can probably be explained 
simply on the basis of arithmetical addition of the individual 
responses. However, it must be emphasized that synergistic 
interactions are by no means ruled out by these experiments. 
Suppressive, or "antergistic" interaction is easier to 
demonstrate. This is assumed to have occurred when the combining 
of two cell populations results in a combined response less than 
that of one of the individual populations. In the SRBC system, 
this phenomenon was suggested in several experiments and was 
convincingly demonstrated in one (Figures 6 and 7). In graft- 
versus-host experiments, it appears that FI thymocytes can exert 
suppressive effects (S. Liebhaber, unpublished data). Cortisone 
resistant FI thymocytes in these studies were even more suppressive 
and in vitro irradiated cortisone resistant thymocytes were among 
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the most suppressive cell populations yet studied. Perhaps signifi¬ 
cantly, in all instances where suppression was observed, this 
phenomenon occurred on or after the peak day of response. 
The significance of interactions between thymocytes is 
difficult to interpret at the present time. It is perhaps most 
useful to think of thymocyte populations as capable of bidirectional 
interactions. It is not possible at this point to say whether 
individual cells may interact in a unidirectional or bidirectional 
manner. 
The experiments reported herein shed little light on the 
actual mechanisms of thymocyte-thymocyte interactions, but what¬ 
ever the explanation turns out to be, certain generalizations 
may be drawn from these and other data: 
The cortisone resistant thymocyte population seems to repre¬ 
sent a more labile cell population with entirely different be¬ 
havior than whole thymocytes in response to antigens. The presence 
of suppressed first order kinetics suggests that these cells may 
be capable of feedback inhibition of themselves. In other experi¬ 
ments, they appear to be capable of suppression of whole thymo¬ 
cytes, and this suppression is potentiated by in vitro irradiation 
of the cortisone resistant thymocytes. 
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The cortisone sensitive thymocytes appear to exert some 
kind of regulatory influence on cortisone resistant thymocytes 
as judged by the marked differences in response to antigen 
between combined populations and isolated cortisone resistant 
thymocytes. In response to a relatively weak antigenic stimulus 
(SRBC) , the cortisone sensitive thymocytes seem to confine them¬ 
selves to regulation of the cortisone sensitive cells; in the 
presence of potent histocompatibility antigens, the cortisone 
sensitive cells seem to be themselves responding as well as 
playing a regulatory role. 
In vitro irradiation of thymocytes appears to enhance their 
suppressive effect on other thymocytes. It has been shown that 
cooperation of immunized T-cells with B-cells in the restoration 
of hemolysins is radiation resistant (81) , but no data is yet 
published to suggest that immunosuppressive actions of T-cells 
are radiation resistant. Such radiation resistance would point 
to either a persistent chemical immunosuppressant (?IgY) or the 
selection by irradiation of an extraordinarily radiation re¬ 
sistant immunosuppressive cell. Alternatively, the possibility 
exists that the effect of radiation is to reduce the background 
DNA synthesis of the suppressor cells, hence resulting in a re¬ 
duced total DNA synthesis. 
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An overall interpretation of thymocyte interactions at this 
point is not possible, other than to say that they appear quite 
complex. It seems clear that at least some thymocyte populations 
are capable of bidirectional interactions. The cortisone sensitive 
population appears to be a highly labile intrathymic cell fraction, 
is capable of vigorous response to antigen and may in turn be con¬ 
trolled by cortisone sensitive thymocytes an by feedback control 
upon itself. Though positive interactions between cortisone re¬ 
sistant thymocytes and other cells have not been shown in these 
experiments, these have not been excluded and it would seem teleo¬ 
logically reasonable to seek these out. 
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5. Possible Physiologic Role of Corticosteroids in Immunity 
In conclusion, a possible role for corticosteroids in the 
regulation of overall immune responsiveness is proposed. It is 
recognized that stress and its accompanying increased cortisol 
secretion rate have far-reaching effects on immune reactivity 
(83, 84), increasing or decreasing the immune response depending 
on experimental conditions. Indeed, Dougherty et al. (5) have 
proposed that varying rates of corticosteroid secretion may be 
an important regulatory influence on the "maturation" rate of 
lymphatic tissue. Blomgren and Andersson (64) have shown differ¬ 
ential responsiveness of thymic cell populations in the process 
of recovery from corticosteroid administration. It is hereby 
speculated that the observed effects of corticosteroids on the 
immune system may be due to their lytic effects on a cortisone- 
sensitive, regulatory cell population in or outside of the thymus. 
Recent experiments (reported in 80) have shown that there is 
an acute deficit of a cell type (Tl) in the spleens of adult thy- 
mectomized mice. Perhaps this is the cortisone sensitive thymo¬ 
cyte whose effects have been measured in the experiments pre¬ 
sented herein. If this is true and if the regulatory role sug¬ 
gested is real, then this could help explain the increased 
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occurrence of autoimmune phenomena in aged mammals whose thymuses 
have involuted and who consequently have a deficiency of these 
cells. 
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